Predictors of response to emergent therapies in paediatric immune thrombocytopenia.

When focusing on non‐responders to all available ET (IVIG, steroids and RhoD if suitable), patients were older, with a median age at diagnosis of 13.6 years (IQR 5.4–16.6) and only 37.5% younger than 10 years old, though this again did not reach statistical significance.

also in 111,027 other papers